Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Acute Generalized Pustular Psoriasis

被引：40
|
作者：
Viguier, Manuelle [1 ,9 ]
Aubin, Francois [2 ,3 ,9 ]
Delaporte, Emmanuel [4 ]
Pages, Cecile
Paul, Carle [5 ,9 ]
Beylot-Barry, Marie [6 ,7 ,9 ]
Goujon, Catherine [8 ,9 ]
Rybojad, Michel
Bachelez, Herve [9 ,10 ]
机构：
[1] Univ Paris Diderot, Hop St Louis, AP HP, Serv Dermatol, F-75475 Paris 10, France
[2] Univ Franche Comte, EA 3181, IFR 133, F-25030 Besancon, France
[3] CHU Besancon, F-25030 Besancon, France
[4] Univ Lille 2, Ctr Hosp Reg Univ, Lille, France
[5] Univ Toulouse 3, Hop Larrey, CHU, F-31062 Toulouse, France
[6] Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France
[7] CHU, Hop Haut Leveque, Serv Dermatol, Bordeaux, France
[8] Ctr Hosp Lyon Sud, Immunol Clin, Lyon, France
[9] Soc Francaise Dermatol, Grp Rech Psoriasis, Paris, France
[10] Hop Necker Enfants Malad, INSERM, U781, Paris, France
来源：
ARCHIVES OF DERMATOLOGY | 2012年 / 148卷 / 12期
关键词：
D O I：
10.1001/2013.jamadermatol.80
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1423 / 1425
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
    Yukari Okubo
    Yoshinori Umezawa
    Shinya Sakurai
    Naoki Hoshii
    Hidemi Nakagawa
    Dermatology and Therapy, 2022, 12 : 1397 - 1415
  • [42] Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
    Okubo, Yukari
    Umezawa, Yoshinori
    Sakurai, Shinya
    Hoshii, Naoki
    Nakagawa, Hidemi
    DERMATOLOGY AND THERAPY, 2022, 12 (06) : 1397 - 1415
  • [43] Long-term efficacy of adalimumab in generalized pustular psoriasis
    Zangrilli, Arianna
    Papoutsaki, Marina
    Talamonti, Marina
    Chimenti, Sergio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (03) : 185 - 187
  • [44] Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding
    Raja, Harish
    Matteson, Eric L.
    Michet, Clement J.
    Smith, Justine R.
    Pulido, Jose S.
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2012, 1 (02):
  • [45] Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis
    Dulgeroglu Erdogdu, Deniz
    Bal, Ajda
    Karaahmet, Ozgur
    Erkoc, Sibel
    Yalcin, Tugba
    Cakci, Aytul
    ARCHIVES OF RHEUMATOLOGY, 2014, 29 (04) : 257 - 266
  • [46] Strategies for Treatment With Anti-Tumor Necrosis Factor Agents in Psoriasis Maintaining Efficacy and Safety for the Long Haul
    Gordon, Kenneth B.
    Gandhi, Mona
    ARCHIVES OF DERMATOLOGY, 2010, 146 (02) : 186 - 188
  • [47] Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature
    Wei, Kebo
    Li, Ping
    He, Xin
    Yang, Dongyue
    Lang, Jing
    Lai, Lingyao
    Xiao, Min
    FRONTIERS IN MEDICINE, 2024, 11
  • [48] Recalcitrant, generalized pustular psoriasis:: rapid and lasting therapeutic response to antitumour necrosis factor-α antibody (infliximab)
    Schmick, K
    Grabbe, J
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (02) : 367 - 367
  • [49] Generalized pustular psoriasis complicated by acute respiratory distress syndrome
    Griffiths, M. R.
    Porter, W.
    Fergusson-Wood, L. A.
    Adriaans, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (02) : 496 - 497
  • [50] Tumor Necrosis Factor Inhibitors May Reduce Cardiovascular Morbidity in Patients With Psoriasis
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    CUTIS, 2020, 105 (02): : 60 - 61
12345